Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/21/2018 | PROTHENA CORP PUBLIC LTD CO | PRTA | Grant | Stock Option (right to buy) | 150k | $15.04 | $2.3M | | 06/21/2018 |
02/21/2018 | PROTHENA CORP PUBLIC LTD CO | PRTA | Grant | Stock Option (right to buy) | 60k | $33.10 | $2M | | 02/21/2018 |
03/01/2017 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 3.1k | $59.28 | $185.3k | | 03/01/2017 |
03/01/2017 | PROTHENA CORP PUBLIC LTD CO | PRTA | Exercise | Stock Option (right to buy) | 3.1k | $22.14 | $69.2k | | 03/01/2017 |
02/22/2017 | PROTHENA CORP PUBLIC LTD CO | PRTA | Grant | Stock Option (right to buy) | 55k | $55.00 | $3M | | 02/22/2017 |
01/04/2017 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 2.7k | $52.27 | $141.8k | | 01/03/2017 |
01/04/2017 | PROTHENA CORP PUBLIC LTD CO | PRTA | Exercise | Stock Option (right to buy) | 2.7k | $22.14 | $60k | | 01/03/2017 |
01/03/2017 | PROTHENA CORP PUBLIC LTD CO | PRTA | Exercise | Stock Option (right to buy) | 413 | $22.14 | $9.1k | | 01/03/2017 |
01/03/2017 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 413 | $52.15 | $21.5k | | 01/03/2017 |
11/09/2016 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 3.1k | $52.19 | $163.1k | | 11/09/2016 |
11/09/2016 | PROTHENA CORP PUBLIC LTD CO | PRTA | Exercise | Stock Option (right to buy) | 3.1k | $22.14 | $69.2k | | 11/09/2016 |
09/01/2016 | PROTHENA CORP PUBLIC LTD CO | PRTA | Exercise | Stock Option (right to buy) | 3.1k | $22.14 | $69.2k | | 09/01/2016 |
09/01/2016 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 3.1k | $52.16 | $163k | | 09/01/2016 |
07/20/2016 | PROTHENA CORP PUBLIC LTD CO | PRTA | Exercise | Stock Option (right to buy) | 9.4k | $22.14 | $207.6k | | 07/20/2016 |
07/20/2016 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 9.4k | $52.14 | $488.8k | | 07/20/2016 |
02/24/2016 | PROTHENA CORP PUBLIC LTD CO | PRTA | Grant | Stock Option(right to buy) | 45k | $34.61 | $1.6M | | 02/24/2016 |
01/04/2016 | PROTHENA CORP PUBLIC LTD CO | PRTA | Exercise | Stock Option (right to buy) | 3.1k | $22.14 | $69.2k | | 01/04/2016 |
01/04/2016 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 600 | $66.55 | $39.9k | | 01/04/2016 |
01/04/2016 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 1.1k | $65.46 | $74.5k | | 01/04/2016 |
01/04/2016 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 1.4k | $64.51 | $89.5k | | 01/04/2016 |
11/02/2015 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 3.1k | $52.14 | $162.9k | | 11/02/2015 |
11/02/2015 | PROTHENA CORP PUBLIC LTD CO | PRTA | Exercise | Stock Option (right to buy) | 3.1k | $22.14 | $69.2k | | 11/02/2015 |
09/01/2015 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 1.1k | $54.85 | $60.3k | | 09/01/2015 |
09/01/2015 | PROTHENA CORP PUBLIC LTD CO | PRTA | Sale | Ordinary Shares, par value $0.01 per share | 2k | $55.77 | $112.9k | | 09/01/2015 |
09/01/2015 | PROTHENA CORP PUBLIC LTD CO | PRTA | Exercise | Stock Option (right to buy) | 3.1k | $22.14 | $69.2k | | 09/01/2015 |
03/11/2015 | PROTHENA CORP PUBLIC LTD CO | PRTA | Grant | Stock Option (right to buy) | 42.5k | $27.81 | $1.2M | | 03/11/2015 |
08/07/2014 | PROTHENA CORP PUBLIC LTD CO | PRTA | Purchase | Ordinary Shares, par value $0.01 per share | 2k | $19.12 | $38.2k | By Trust | 08/07/2014 |
05/01/2014 | PROTHENA CORP PUBLIC LTD CO | PRTA | Grant | Stock Option (right to buy) | 100k | $22.14 | $2.2M | | 05/01/2014 |
03/18/2013 | COMPLETE GENOMICS INC | GNOM | Disposition | Stock Option (right to buy) | 100k | $3.01 | $301k | | 03/14/2013 |
04/02/2012 | COMPLETE GENOMICS INC | GNOM | Grant | Stock Option (Right to buy) | 100k | $3.01 | $301k | | 04/02/2012 |